Latest news & insights

PharmaTimes: News RSS

• Bayer's finerenone hits targets in diabetes/kidney disease trial 10th July 2020
  The drug hit primary and secondary goals of the Phase III FIDELIO-DKD renal outcomes study
• Research journals commit to action on equality 10th July 2020
  Joint commitment led by the Royal Society of Chemistry, which has created a framework to reduce bias and discrimination that it is hoped 'will help reshape journals all over the world'
• US priority review for AZ' Brilinta/aspirin combination 10th July 2020
  Brilinta/aspirin combo could be the first US-approved dual antiplatelet therapy to cut risk of second stroke
• Charity warns of 'catastrophic' effect of COVID-19 on stroke research 10th July 2020
  UK’s leading stroke charity warns research faces long-term threat due to coronavirus pandemic
• NICE backing for Takeda's Adcetris for rare lymphoma 10th July 2020
  Standard of care in untreated systemic anaplastic large cell lymphoma (sALCL) has not changed in several decades